4-Bromo-5-methyl-1H-pyrazol-3-ylamine, 95.0%, 100g

(3-FLUORO-2-IODOPHENYL)METHANOL, 95.0%, 25g

BenzaMide, 4-[[2-[3,5-bis(trifluoroMethyl)phenyl]-4,5-bis(4-Methoxyphenyl)-1H-iMidazol-1-yl]Methyl]-, 500mg

(1S,3aR,4S,7aS)-1-((S)-1-(3-hydroxy-3-methylbutoxy)ethyl)-7a-methyloctahydro-1H-inden-4-ol, 97%, 250mg

2-Oxaspiro[3.3]heptan-6-ol, 95.0%, 1g

6-(Methylthio)-9H-purine, 97.0%, 1g

3-G1 2AB (500pmol/vial)1vial

1-Allyl-[1,4]diazepane, 98.0%, 1g

N-(furan-2-ylmethyl)-2-(2-methyl-1H-indol-3-yl)ethan-1-amine hydrochloride, 95.0%, 250mg

2-Bromo-5-(2-methoxyethoxy)pyrazine, 250mg

1-(Phenanthren-3-yl)ethanone, 95.0%, 1g

5-amino-1-methyl-2-(methylthio)-1H-imidazole-4-carboxamide, 95.0%, 250mg

2-Mesitylethanol, 95.0%, 1g